|
RPL13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.982990E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.395400E-03 |
| Normal-vs-Stage2 |
1.630020E-01 |
| Normal-vs-Stage3 |
9.999600E-04 |
| Normal-vs-Stage4 |
4.517700E-03 |
| Stage1-vs-Stage2 |
3.062000E-01 |
| Stage1-vs-Stage3 |
3.764800E-01 |
| Stage1-vs-Stage4 |
8.033200E-01 |
| Stage2-vs-Stage3 |
1.248390E-01 |
| Stage2-vs-Stage4 |
2.844400E-01 |
| Stage3-vs-Stage4 |
6.042000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.223910E-03 |
| Normal-vs-AfricanAmerican |
7.252400E-02 |
| Normal-vs-Asian |
3.474300E-02 |
| Caucasian-vs-AfricanAmerican |
7.528600E-01 |
| Caucasian-vs-Asian |
8.085000E-01 |
| AfricanAmerican-vs-Asian |
9.212600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.082410E-03 |
| Normal-vs-Female |
4.364000E-03 |
| Male-vs-Female |
5.827400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.449900E-04 |
| Normal-vs-Age(41-60Yrs) |
3.542800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.698060E-02 |
| Normal-vs-Age(81-100Yrs) |
1.507970E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.512600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.020600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.255400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.821800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.336800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.571200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.719600E-01 |
| Classical-VS-Follicular |
3.198000E-01 |
| Classical-VS-Other |
3.366600E-01 |
| Classical-VS-Normal |
1.038190E-03 |
| Tall-VS-Follicular |
6.696000E-01 |
| Tall-VS-Other |
3.482600E-01 |
| Tall-VS-Normal |
4.111900E-02 |
| Follicular-VS-Other |
1.388800E-01 |
| Follicular-VS-Normal |
6.698100E-02 |
| Other-VS-Normal |
2.941800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.637500E-03 |
| Normal-vs-N1 |
6.156200E-04 |
| N0-vs-N1 |
2.535800E-01 |
|
|
